New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children

Diana Domnitei, Vishal MadaanDepartment of Psychiatry, Creighton University Medical Center, Omaha, NE, USAAbstract: Treatment guidelines from the American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics state that stimulant medications have the most evidence for saf...

Full description

Bibliographic Details
Main Authors:	Diana Domnitei, Vishal Madaan
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-05-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/new-and-extended-action-treatments-in-the-management-of-adhd-a-critica-a4457

Similar Items

Update on optimal use of lisdexamfetamine in the treatment of ADHD
by: Madaan V, et al.
Published: (2013-07-01)

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
by: Maneeton N, et al.
Published: (2014-10-01)

Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
by: Najib J
Published: (2012-05-01)

Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation
by: Matthew D. Lyons MD, et al.
Published: (2017-05-01)

Farmakologisk långtidsbehandling vid ADHD : Hur skiljer sig substanserna metylfenidat, lisdexamfetamin och atomoxetin?
by: Andersson, Lea
Published: (2019)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
by: Jadwiga Najib, et al.
Published: (2017-08-01)

Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials
by: Maneeton B, et al.
Published: (2015-04-01)

Lisdexamfetamine Toxicity with Delayed Hypertensive Emergency
by: Rachel Schult, et al.
Published: (2017-12-01)

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
by: Weisler Richard, et al.
Published: (2009-08-01)

A critical appraisal of atomoxetine in the management of ADHD
by: Childress AC
Published: (2015-12-01)

Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
by: Paulo Mattos
Published: (2014-03-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
by: Kristi R. Griffiths, et al.
Published: (2021-08-01)

Treatment of ADHD: Guanfacine Extended Release in ADHD
by: J Gordon Millichap, et al.
Published: (2014-08-01)

Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient&nbsp; onsiderations and the role of lisdexamfetamine
by: Brian J Cowles
Published: (2009-12-01)

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
by: Guerdjikova AI, et al.
Published: (2016-04-01)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
by: Tara Burleigh, et al.
Published: (2020-08-01)

Traumatic Brain Injury-Related Attention Deficits in Children: A Controlled Treatment Trial with Lisdexamfetamine Dimesylate (Vyvanse)
by: Michael G. Tramontana, et al.
Published: (2021-01-01)

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
by: Patrick C. Dolder, et al.
Published: (2017-09-01)

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
by: Michael Pennick
Published: (2010-06-01)

The Dietetic Treatment and Logistic Action of Family with ADHD Children
by: Wei-Min Liu, et al.
Published: (2013)

Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents
by: Bello NT
Published: (2015-06-01)

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
by: Adrian Dunlop, et al.
Published: (2021-06-01)

Antioxidant effect of simvastatin throught oxidative imbalance caused by lisdexamfetamine dimesylate
by: Guilherme A. Eger, et al.
Published: (2016-03-01)

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
by: Gitanjali Srivastava, et al.
Published: (2019-02-01)

Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
by: Ori Toker, et al.
Published: (2010-05-01)

Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds
by: Shenghua Gao, et al.
Published: (2018-11-01)

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
by: Weisler RH, et al.
Published: (2013-12-01)

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
by: Mattingly Greg W, et al.
Published: (2013-01-01)

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
by: Ermer J, et al.
Published: (2013-02-01)

New treatment options for fibromyalgia: critical appraisal of duloxetine
by: Nurcan &Uuml;&ccedil;eyler, et al.
Published: (2008-06-01)

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD
by: Pardo A, et al.
Published: (2021-07-01)

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
by: Childress Ann C, et al.
Published: (2009-06-01)

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
by: Jain Rakesh, et al.
Published: (2011-11-01)

Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
by: Sharman J, et al.
Published: (2014-11-01)

Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
by: Fornaro M, et al.
Published: (2016-07-01)

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD
by: Kooij Sandra JJ, et al.
Published: (2010-09-01)

Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
by: Gould HJ III, et al.
Published: (2015-10-01)

Post-marketing evaluation of ADHD drug treatment in children and young adults
by: McCarthy, Suzanne
Published: (2009)

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
by: Childress Ann C, et al.
Published: (2010-12-01)